CYC.AU Cyclopharm Ltd

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
0.4250 AUD
Close of Nov 1, 2026
0.3300 1.29
Market cap
AUD 53.4M
P/E
-
P/B
1.68x
ROE
-110.4%
Dividend yield
-
Fundamental score
1.4/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is CYC.AU undervalued?

Graham number

The Graham number of Cyclopharm Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cyclopharm Ltd fundamental analysis

6 of 21 checks passed

ROE 0/2

Low return on equity (-110.4%), below 10%.

ROA 0/1

Return on assets (-70.8%) is below the industry median (-35.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-21.9%) is below the industry median (24.9%).

Revenue Growth 2/2

Revenue grew 11.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (24.5%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Cash Runway 0/2

Cash covers 0.4 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (1.7x) is below the industry median (4.0x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Cyclopharm Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cyclopharm Ltd

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serve…

Full company profile